Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIP regimen in poor-prognosis disseminated non-seminomatous germ cell tumors
NCT02414685Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2015
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, ifosfamide, cisplatin in non-seminomatous germ cell tumor (NSGCT), sponsored by National Cancer Institute. Started Apr 2015; status: completed.
02
Drugs
paclitaxelifosfamidecisplatin
03
Conditions
non-seminomatous germ cell tumor (NSGCT)
Beyond the preview
Go deeper on NCT02414685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02414685.